NYSE:ENFN Enfusion (ENFN) Stock Price, News & Analysis → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free ENFN Stock Alerts $9.24 +0.13 (+1.43%) (As of 04:00 PM ET) Add Compare Share Share Today's Range$9.07▼$9.2450-Day Range$8.18▼$9.6652-Week Range$7.37▼$11.56Volume212,938 shsAverage Volume385,912 shsMarket Capitalization$1.18 billionP/E Ratio115.51Dividend YieldN/APrice Target$9.33 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Enfusion alerts: Email Address Enfusion MarketRank™ Stock AnalysisAnalyst RatingReduce1.67 Rating ScoreUpside/Downside2.0% Upside$9.33 Price TargetShort InterestHealthy4.93% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.64Based on 3 Articles This WeekInsider TradingSelling Shares$1,179 Sold Last QuarterProj. Earnings Growth142.86%From $0.07 to $0.17 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.51 out of 5 starsComputer And Technology Sector353rd out of 582 stocksPrepackaged Software Industry132nd out of 198 stocks 0.8 Analyst's Opinion Consensus RatingEnfusion has received a consensus rating of Reduce. The company's average rating score is 1.67, and is based on 1 buy rating, 2 hold ratings, and 3 sell ratings.Amount of Analyst CoverageEnfusion has only been the subject of 3 research reports in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted4.93% of the float of Enfusion has been sold short.Short Interest Ratio / Days to CoverEnfusion has a short interest ratio ("days to cover") of 5.5.Change versus previous monthShort interest in Enfusion has recently decreased by 25.17%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldEnfusion does not currently pay a dividend.Dividend GrowthEnfusion does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ENFN. Previous Next 2.6 News and Social Media Coverage News SentimentEnfusion has a news sentiment score of 0.64. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.50 average news sentiment score of Computer and Technology companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Enfusion this week, compared to 2 articles on an average week.Search InterestOnly 2 people have searched for ENFN on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Enfusion insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,179.00 in company stock.Percentage Held by Insiders39.18% of the stock of Enfusion is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions81.05% of the stock of Enfusion is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Enfusion are expected to grow by 142.86% in the coming year, from $0.07 to $0.17 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Enfusion is 114.39, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 137.39.Price to Earnings Ratio vs. SectorThe P/E ratio of Enfusion is 114.39, which means that it is trading at a less expensive P/E ratio than the Computer and Technology sector average P/E ratio of about 228.45.Price to Earnings Growth RatioEnfusion has a PEG Ratio of 2.71. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioEnfusion has a P/B Ratio of 15.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About Enfusion Stock (NYSE:ENFN)Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers Accounting/General Ledger System, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.Read More ENFN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ENFN Stock News HeadlinesApril 18, 2024 | businesswire.comEnfusion Announces Date of First Quarter 2024 ResultsApril 17, 2024 | morningstar.comEnfusion Inc Class AApril 19, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. April 12, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFNApril 12, 2024 | americanbankingnews.comEnfusion, Inc. (NYSE:ENFN) Receives Consensus Rating of "Reduce" from BrokeragesApril 4, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFNApril 4, 2024 | msn.comThe 3 Most Undervalued Under-$10 Stocks to Buy in April 2024April 2, 2024 | finance.yahoo.comWill Enfusion (ENFN) Grow Revenue And Expand Margins In The Future?April 19, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. April 2, 2024 | businesswire.comConnexPay Appoints Ben Peters as Chief Executive OfficerMarch 27, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFNMarch 22, 2024 | markets.businessinsider.comEnfusion’s Growth Strategy Met with Sell Rating Amid Market and Strategic ChallengesMarch 21, 2024 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Technology Stocks: GoDaddy (GDDY) and Enfusion (ENFN)March 20, 2024 | markets.businessinsider.comStifel Nicolaus Keeps Their Buy Rating on Enfusion (ENFN)March 19, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFNMarch 15, 2024 | markets.businessinsider.comWall Street Favorites: 3 Under-$10 Stocks with Strong Buy Ratings for March 2024March 14, 2024 | seekingalpha.comEnfusion, Inc. (ENFN) Q4 2023 Earnings Call TranscriptMarch 14, 2024 | finance.yahoo.comEnfusion, Inc. (NYSE:ENFN) Q4 2023 Earnings Call TranscriptMarch 13, 2024 | markets.businessinsider.comAnalysts Offer Insights on Technology Companies: Copperleaf Tech (OtherCPLFF), Rackspace Technology (RXT) and Enfusion (ENFN)March 12, 2024 | markets.businessinsider.comWilliam Blair Reaffirms Their Buy Rating on Enfusion (ENFN)March 12, 2024 | msn.comEnfusion reports mixed Q4 results; initiates FY24 outlookMarch 12, 2024 | finance.yahoo.comEnfusion Announces Fourth Quarter 2023 Results and Full Year 2023 ResultsMarch 11, 2024 | benzinga.comEarnings Outlook For EnfusionMarch 6, 2024 | benzinga.comMajor Purchase Alert: Oleg Movchan Invests $120K In Enfusion StockFebruary 29, 2024 | msn.comGoldman Sachs Downgrades Enfusion (ENFN)February 28, 2024 | msn.comEnfusion stock retreats after Goldman downgrades to SellFebruary 28, 2024 | markets.businessinsider.comEnfusion Stock Sell Rating: Conservative Revenue Growth and Market Challenges AheadSee More Headlines Receive ENFN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Enfusion and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/12/2024Today4/19/2024Next Earnings (Confirmed)5/09/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorComputer and Technology Industry Prepackaged software Sub-IndustryN/A Current SymbolNYSE:ENFN CUSIPN/A CIK1868912 Webwww.enfusion.com Phone312-253-9800FaxN/AEmployees1,102Year FoundedN/APrice Target and Rating Average Stock Price Target$9.33 High Stock Price Target$11.00 Low Stock Price Target$8.00 Potential Upside/Downside+1.8%Consensus RatingReduce Rating Score (0-4)1.67 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)$0.08 Trailing P/E Ratio114.64 Forward P/E Ratio131.00 P/E Growth2.71Net Income$6.03 million Net Margins3.45% Pretax Margin6.58% Return on Equity10.30% Return on Assets7.78% Debt Debt-to-Equity RatioN/A Current Ratio3.44 Quick Ratio3.44 Sales & Book Value Annual Sales$174.54 million Price / Sales6.73 Cash Flow$0.14 per share Price / Cash Flow64.53 Book Value$0.61 per share Price / Book15.03Miscellaneous Outstanding Shares128,070,000Free Float77,892,000Market Cap$1.17 billion OptionableOptionable Beta1.00 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMr. Oleg Movchan (Age 49)CEO & Director Comp: $876.34kMr. Bradley Herring (Age 53)Chief Financial Officer Comp: $267.05kMs. Bronwen Bastone (Age 51)Chief People Officer Comp: $566.25kMr. Stephen MalherbeManaging PartnerMr. Neal PawarChief Operating OfficerMs. Valeria Gutowski (Age 42)Chief Accounting Officer Mr. Daniel Groman (Age 35)Chief Technology Officer Mr. Ignatius Tochukwu NjokuHead of Investor RelationsMatt CampobassoGeneral CounselMr. Joseph DefeoGlobal Head of Managed Services ProductionMore ExecutivesKey CompetitorsCouchbaseNASDAQ:BASEPDF SolutionsNASDAQ:PDFSZuoraNYSE:ZUOSoundHound AINASDAQ:SOUNHello GroupNASDAQ:MOMOView All CompetitorsInsiders & InstitutionsWasatch Advisors LPBought 201,771 shares on 4/18/2024Ownership: 0.618%Allspring Global Investments Holdings LLCBought 4,772 shares on 4/18/2024Ownership: 0.004%Vanguard Group Inc.Bought 113,704 shares on 3/11/2024Ownership: 2.825%Wellington Management Group LLPBought 26,464 shares on 3/5/2024Ownership: 0.384%Goldman Sachs Group Inc.Sold 87,922 shares on 3/1/2024Ownership: 0.043%View All Insider TransactionsView All Institutional Transactions ENFN Stock Analysis - Frequently Asked Questions Should I buy or sell Enfusion stock right now? 6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Enfusion in the last twelve months. There are currently 3 sell ratings, 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "reduce" ENFN shares. View ENFN analyst ratings or view top-rated stocks. What is Enfusion's stock price target for 2024? 6 brokerages have issued twelve-month price objectives for Enfusion's shares. Their ENFN share price targets range from $8.00 to $11.00. On average, they predict the company's share price to reach $9.33 in the next twelve months. This suggests a possible upside of 2.0% from the stock's current price. View analysts price targets for ENFN or view top-rated stocks among Wall Street analysts. How have ENFN shares performed in 2024? Enfusion's stock was trading at $9.70 at the start of the year. Since then, ENFN stock has decreased by 5.7% and is now trading at $9.15. View the best growth stocks for 2024 here. Are investors shorting Enfusion? Enfusion saw a decline in short interest in the month of March. As of March 31st, there was short interest totaling 2,260,000 shares, a decline of 25.2% from the March 15th total of 3,020,000 shares. Based on an average trading volume of 409,100 shares, the days-to-cover ratio is presently 5.5 days. Approximately 4.9% of the shares of the stock are sold short. View Enfusion's Short Interest. When is Enfusion's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our ENFN earnings forecast. How can I listen to Enfusion's earnings call? Enfusion will be holding an earnings conference call on Thursday, May 9th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link. How were Enfusion's earnings last quarter? Enfusion, Inc. (NYSE:ENFN) announced its earnings results on Tuesday, March, 12th. The company reported $0.01 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.03 by $0.02. The firm had revenue of $46.49 million for the quarter, compared to analyst estimates of $45.56 million. Enfusion had a net margin of 3.45% and a trailing twelve-month return on equity of 10.30%. What guidance has Enfusion issued on next quarter's earnings? Enfusion issued an update on its FY 2024 earnings guidance on Tuesday, March, 12th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $200.0 million-$210.0 million, compared to the consensus revenue estimate of $202.3 million. When did Enfusion IPO? Enfusion (ENFN) raised $300 million in an initial public offering (IPO) on Thursday, October 21st 2021. The company issued 18,750,000 shares at a price of $15.00-$17.00 per share. Who are Enfusion's major shareholders? Enfusion's stock is owned by a number of retail and institutional investors. Top institutional investors include Wasatch Advisors LP (0.62%) and Allspring Global Investments Holdings LLC (0.00%). Insiders that own company stock include Bradley Herring, Bronwen Bastone, Dan Groman, Deirdre Somers, Hillhouse Investment Managemen, Matthew Campobasso, Oleg Movchan, Roy Luo, Stephen Malherbe, Tarek Hammoud and Valeria Gutowski. View institutional ownership trends. How do I buy shares of Enfusion? Shares of ENFN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:ENFN) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIYour Money is Not SafeAmerican AlternativeHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceSHOCKING Crypto Leak…Crypto 101 MediaMy biggest AI fearParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enfusion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.